skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 208  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove subject: Humans remove subject: Risk Factors remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
Material Type:
Article 		Add to My Research

PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

BMC cancer, 2015-08, Vol.15 (1), p.602, Article 602 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Owadally et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1598-x ;PMID: 26311526

Full text available

Citations Cited by
2
Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population
Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population
Material Type:
Article 		Add to My Research

Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population

BMC cancer, 2021-01, Vol.21 (1), p.94-94, Article 94 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07773-6 ;PMID: 33482771

Full text available

Citations Cited by
3
Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis
Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis

BMC cancer, 2019-06, Vol.19 (1), p.543-28, Article 543 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5642-0 ;PMID: 31170936

Full text available

Citations Cited by
4
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment
Material Type:
Article 		Add to My Research

Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment

BMC cancer, 2022-04, Vol.22 (1), p.368-368, Article 368 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09439-x ;PMID: 35392843

Full text available

Citations Cited by
5
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

BMC cancer, 2022-03, Vol.22 (1), p.270-270, Article 270 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09325-6 ;PMID: 35287627

Full text available

Citations Cited by
6
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
Material Type:
Article 		Add to My Research

Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice

BMC cancer, 2019-02, Vol.19 (1), p.151-151, Article 151 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5354-5 ;PMID: 30764783

Full text available

Citations Cited by
7
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer
A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer
Material Type:
Article 		Add to My Research

A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer

BMC cancer, 2021-11, Vol.21 (1), p.1221-1221, Article 1221 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08975-2 ;PMID: 34774009

Full text available

Citations Cited by
8
INHBA is a prognostic predictor for patients with colon adenocarcinoma
INHBA is a prognostic predictor for patients with colon adenocarcinoma
Material Type:
Article 		Add to My Research

INHBA is a prognostic predictor for patients with colon adenocarcinoma

BMC cancer, 2020-04, Vol.20 (1), p.305-305, Article 305 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06743-2 ;PMID: 32293338

Full text available

Citations Cited by
9
Identification of a pyroptosis-related prognostic signature in breast cancer
Identification of a pyroptosis-related prognostic signature in breast cancer
Material Type:
Article 		Add to My Research

Identification of a pyroptosis-related prognostic signature in breast cancer

BMC cancer, 2022-04, Vol.22 (1), p.429-429, Article 429 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09526-z ;PMID: 35443644

Full text available

Citations Cited by
10
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma

BMC cancer, 2020-06, Vol.20 (1), p.494-494, Article 494 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06995-y ;PMID: 32487048

Full text available

Citations Cited by
11
Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma

BMC cancer, 2023-01, Vol.23 (1), p.25-25, Article 25 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10461-2 ;PMID: 36611155

Full text available

Citations Cited by
12
Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer
Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer
Material Type:
Article 		Add to My Research

Malnutrition and visceral obesity predicted adverse short-term and long-term outcomes in patients undergoing proctectomy for rectal cancer

BMC cancer, 2023-06, Vol.23 (1), p.576-576, Article 576 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11083-y ;PMID: 37349711

Full text available

Citations Cited by
13
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma
Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Serum long non-coding RNA SCARNA10 serves as a potential diagnostic biomarker for hepatocellular carcinoma

BMC cancer, 2022-04, Vol.22 (1), p.431-431, Article 431 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09530-3 ;PMID: 35443674

Full text available

Citations Cited by
14
Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets
Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets
Material Type:
Article 		Add to My Research

Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets

BMC cancer, 2022-03, Vol.22 (1), p.288-288, Article 288 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09380-z ;PMID: 35300639

Full text available

Citations Cited by
15
Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis
Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis

BMC cancer, 2023-07, Vol.23 (1), p.644-644, Article 644 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11049-0 ;PMID: 37430191

Full text available

Citations Cited by
16
Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma
Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma
Material Type:
Article 		Add to My Research

Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma

BMC cancer, 2024-04, Vol.24 (1), p.435-435 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12209-6 ;PMID: 38589858

Full text available

Citations Cited by
17
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis
Material Type:
Article 		Add to My Research

Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis

BMC cancer, 2022-03, Vol.22 (1), p.287-287, Article 287 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09413-7 ;PMID: 35300634

Full text available

Citations Cited by
18
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial
Material Type:
Article 		Add to My Research

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial

BMC cancer, 2024-02, Vol.24 (1), p.260-260 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-11987-3 ;PMID: 38402173

Full text available

Citations Cited by
19
Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer
Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer
Material Type:
Article 		Add to My Research

Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer

BMC cancer, 2022-05, Vol.22 (1), p.550-550, Article 550 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09602-4 ;PMID: 35578198

Full text available

Citations Cited by
20
A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration
A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration
Material Type:
Article 		Add to My Research

A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration

BMC cancer, 2021-12, Vol.21 (1), p.1311-1311, Article 1311 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-09046-2 ;PMID: 34876094

Full text available

Citations Cited by

Results 1 - 20 of 208  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait